Sunday, June 14, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 272 of 1,261

  1. US 11299553

    Anti-plasma kallikrein antibodies

    Takeda Pharmaceutical Company Limited · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  2. US 11299532

    Anti-VEGF protein compositions and methods for producing the same

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  3. US 11299533

    Purification of factor VIII subspecies

    Takeda Pharmaceutical Company Limited · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  4. US 11299515

    Optimized peptides for targeting human nerves and their use in image guided surgery, diagnostics and therapeutic

    The Regents of the University of California · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  5. US 11299512

    Cyclic di-nucleotide compounds and methods of use

    The Board of Regents of the University of Texas System · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  6. US 11299490

    Benzenesulfonamide compounds and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  7. US 11299486

    Benzazole compounds and methods for making and using the compounds

    Rigel Pharmaceuticals, Inc. · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  8. US 11299496

    Ligands for alpha-7 nicotinic acetylcholine receptors and methods of treating neurological and inflammatory conditions

    Northwestern University · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  9. US 11299517

    Recombinant vaccine against Marek's disease and Newcastle disease

    The United States of America, as represented by the Secretary of Agriculture · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  10. US 11299482

    Salt and crystal form of modified andrographolide compound and preparation method thereof

    Medshine Discovery Inc. · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  11. US 11298561

    Method of treating multi-drug resistance biofilm using targeted laser and antibiotics

    United States of America as represented by the Secretary of the Air Force · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  12. US 11299476

    Dopamine D3 receptor selective antagonists/partial agonists; method of making; and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  13. US 11299475

    Prostacyclin receptor agonist

    Medshine Discovery Inc. · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  14. US 11298530

    Synergistic therapies for intervertebral disc degeneration

    Discure Technologies Ltd · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  15. US 11298413

    Vaccine compositions comprising C—C motif chemokine 22 (CCL22) or fragments thereof

    IO Biotech ApS · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  16. US 11298378

    Materials and methods for engineering cells and uses thereof in immuno-oncology

    CRISPR THERAPEUTICS AG · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  17. US 11298345

    Compounds that modulates AMPA receptor function

    University College Cardiff Consultants Limited · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  18. US 11298320

    Liposomal apparatus and manufacturing methods

    ARBUTUS BIOPHARMA CORPORATION · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  19. US 11298317

    Alcoholic compositions having a lowered risk of acetaldehydemia

    Deuteria Beverages, LLC · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  20. US 11291707

    Polypeptide-polymer conjugates and methods of use thereof

    The Regents of the University of California · Granted Apr 5, 2022 · Expires Mar 31, 2042

    granted

  21. US 11291836

    Minimally invasive dermal electroporation device

    Inovio Pharmaceuticals, Inc. · Granted Apr 5, 2022 · Expires Mar 31, 2042

    granted

  22. US 11291687

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Apr 5, 2022 · Expires Mar 31, 2042

    granted

  23. US 11291667

    Combination therapy involving diaryl macrocyclic compounds

    TURNING POINT THERAPEUTICS, INC. · Granted Apr 5, 2022 · Expires Mar 31, 2042

    granted

  24. US 11291663

    Methods of treating cancer with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted Apr 5, 2022 · Expires Mar 31, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.